 | MGG | 表記: | 2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO-PENTANOIC ACID | 組成式: | C9 H17 N4 O5 | SMILES: | O=C(NC(C(=O)O)CCCNC(=[NH2+])N)CC(=O)O | InChi: | InChI=1S/C9H16N4O5/c10-9(11)12-3-1-2-5(8(17)18)13-6(14)4-7(15)16/h5H,1-4H2,(H,13,14)(H,15,16)(H,17,18)(H4,10,11,12)/p+1/t5-/m1/s1 | 別名: | D-ARGININE WITH 3-OXO-PROPIONIC ACID MODIFICATION | 定義日: | 1999-08-25 | 最終更新日: | 2024-09-27 | 識別子(ID): | amino({(4R)-4-carboxy-4-[(carboxyacetyl)amino]butyl}amino)methaniminium |
|
 | MGN | 表記: | 2-METHYL-GLUTAMINE | 組成式: | C6 H12 N2 O3 | SMILES: | O=C(N)CCC(N)(C(=O)O)C | InChi: | InChI=1S/C6H12N2O3/c1-6(8,5(10)11)3-2-4(7)9/h2-3,8H2,1H3,(H2,7,9)(H,10,11)/t6-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-methyl-L-glutamine |
|
 | MH0 | 表記: | Mesoheme | 組成式: | C34 H36 Fe N4 O4 | SMILES: | O=C(O)CCC1=C(C2=CC=6C(=C(C5=CC=4C(=C(C3=CC=7C(=C(C8=CC1=N2[Fe](N3=4)(N5=6)N=78)CCC(=O)O)C)C)CC)C)CC)C | InChi: | InChI=1S/C34H36N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | 定義日: | 2013-05-03 | 最終更新日: | 2024-09-27 | 公開日: | 2013-07-03 | 識別子(ID): | [3,3'-(7,12-diethyl-3,8,13,17-tetramethylporphine-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~)dipropanoic acid]iron |
|
 | 0W0 | 表記: | (4R,5S,8Z)-8-(2-amino-1,3-thiazol-4-yl)-1-[3-(1,5-dihydroxy-4-oxo-1,4-dihydropyridin-2-yl)-1,2-oxazol-5-yl]-5-formyl-11,11-dimethyl-1,7-dioxo-4-(sulfoamino)-10-oxa-2,6,9-triazadodec-8-en-12-oic acid | 組成式: | C22 H24 N8 O13 S2 | SMILES: | O=C1C=C(N(O)C=C1O)c2noc(c2)C(=O)NCC(NS(=O)(=O)O)C(C=O)NC(=O)C(=NOC(C(=O)O)(C)C)/c3nc(sc3)N | InChi: | InChI=1S/C22H24N8O13S2/c1-22(2,20(36)37)43-28-17(12-8-44-21(23)26-12)19(35)25-11(7-31)10(29-45(39,40)41)5-24-18(34)16-3-9(27-42-16)13-4-14(32)15(33)6-30(13)38/h3-4,6-8,10-11,29,33,38H,5H2,1-2H3,(H2,23,26)(H,24,34)(H,25,35)(H,36,37)(H,39,40,41)/b28-17-/t10-,11-/m1/s1 | 定義日: | 2012-07-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-10-12 | 識別子(ID): | (4R,5S,8Z)-8-(2-amino-1,3-thiazol-4-yl)-1-[3-(1,5-dihydroxy-4-oxo-1,4-dihydropyridin-2-yl)-1,2-oxazol-5-yl]-5-formyl-11,11-dimethyl-1,7-dioxo-4-(sulfoamino)-10-oxa-2,6,9-triazadodec-8-en-12-oic acid |
|
 | MH6 | 表記: | 3-hydroxy-2-iminopropanoic acid | 組成式: | C3 H5 N O3 | SMILES: | O=C(O)C(=[N@H])CO | InChi: | InChI=1S/C3H5NO3/c4-2(1-5)3(6)7/h4-5H,1H2,(H,6,7)/b4-2+ | 定義日: | 2008-03-11 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2E)-3-hydroxy-2-iminopropanoic acid |
|
 | MH8 | 表記: | (2S)-2-amino-2-methylhept-6-enoic acid | 組成式: | C8 H15 N O2 | SMILES: | O=C(O)C(N)(CCC/C=C)C | InChi: | InChI=1S/C8H15NO2/c1-3-4-5-6-8(2,9)7(10)11/h3H,1,4-6,9H2,2H3,(H,10,11)/t8-/m0/s1 | 定義日: | 2015-02-04 | 最終更新日: | 2024-09-27 | 公開日: | 2015-09-09 | 識別子(ID): | (2S)-2-amino-2-methylhept-6-enoic acid |
|
 | MH9 | 表記: | (2E,4E)-DODECA-2,4-DIENOIC ACID | 組成式: | C12 H20 O2 | SMILES: | O=C(O)C=CC=CCCCCCCC | InChi: | InChI=1S/C12H20O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h8-11H,2-7H2,1H3,(H,13,14)/b9-8+,11-10+ | 定義日: | 2011-03-28 | 最終更新日: | 2024-09-27 | 公開日: | 2012-08-24 | 識別子(ID): | (2E,4E)-dodeca-2,4-dienoic acid |
|
 | 0W5 | 表記: | (2E,4E)-11-methyldodeca-2,4-dienoic acid | 組成式: | C13 H22 O2 | SMILES: | O=C(O)C=CC=CCCCCCC(C)C | InChi: | InChI=1S/C13H22O2/c1-12(2)10-8-6-4-3-5-7-9-11-13(14)15/h5,7,9,11-12H,3-4,6,8,10H2,1-2H3,(H,14,15)/b7-5+,11-9+ | 定義日: | 2012-07-19 | 最終更新日: | 2024-09-27 | 公開日: | 2012-10-19 | 識別子(ID): | (2E,4E)-11-methyldodeca-2,4-dienoic acid |
|
 | 0W6 | 表記: | (4S)-4-aminopentanoic acid | 組成式: | C5 H11 N O2 | SMILES: | O=C(O)CCC(N)C | InChi: | InChI=1S/C5H11NO2/c1-4(6)2-3-5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | 別名: | (2E,4S)-4-aminopent-2-enoic acid, Bound form | 定義日: | 2012-07-19 | 最終更新日: | 2024-09-27 | 公開日: | 2012-10-19 | 識別子(ID): | (4S)-4-aminopentanoic acid |
|
 | MHC | 表記: | 3-MERCAPTO-1-(1,3,4,9-TETRAHYDRO-B-CARBOLIN-2-YL)-PROPAN-1-ONE | 組成式: | C14 H16 N2 O S | SMILES: | O=C(N3CCc2c1ccccc1nc2C3)CCS | InChi: | InChI=1S/C14H16N2OS/c17-14(6-8-18)16-7-5-11-10-3-1-2-4-12(10)15-13(11)9-16/h1-4,15,18H,5-9H2 | 定義日: | 2002-12-06 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-oxo-3-(1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)propane-1-thiol |
|
 | MHE | 表記: | 5,5-dimethyl-2-oxohexanoic acid | 組成式: | C8 H14 O3 | SMILES: | O=C(C(=O)O)CCC(C)(C)C | InChi: | InChI=1S/C8H14O3/c1-8(2,3)5-4-6(9)7(10)11/h4-5H2,1-3H3,(H,10,11) | 定義日: | 2008-06-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | 5,5-dimethyl-2-oxohexanoic acid |
|
 | MHH | 表記: | methyl hydrogen (R)-hexylphosphonate | 組成式: | C7 H17 O3 P | SMILES: | O=P(O)(OC)CCCCCC | InChi: | InChI=1S/C7H17O3P/c1-3-4-5-6-7-11(8,9)10-2/h3-7H2,1-2H3,(H,8,9) | 定義日: | 2008-01-28 | 最終更新日: | 2024-09-27 | 識別子(ID): | methyl hydrogen (R)-hexylphosphonate |
|
 | MHL | 表記: | N-METHYL-4-HYDROXY-LEUCINE | 組成式: | C7 H15 N O3 | SMILES: | O=C(O)C(NC)CC(O)(C)C | InChi: | InChI=1S/C7H15NO3/c1-7(2,11)4-5(8-3)6(9)10/h5,8,11H,4H2,1-3H3,(H,9,10)/t5-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 4-hydroxy-N-methyl-L-leucine |
|
 | MHO | 表記: | S-OXYMETHIONINE | 組成式: | C5 H11 N O3 S | SMILES: | O=C(O)C(N)CCS(=O)C | InChi: | InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-,10-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2S)-2-amino-4-[(S)-methylsulfinyl]butanoic acid |
|
 | 0WN | 表記: | N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)butanamide | 組成式: | C24 H27 Cl F N5 O3 | SMILES: | Fc1ccc(cc1Cl)Nc4ncnc3cc(OC2CCOC2)c(cc34)NC(=O)CCCN(C)C | InChi: | InChI=1S/C24H27ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h5-6,10-12,14,16H,3-4,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/t16-/m0/s1 | 別名: | Afatinib, bound form | 定義日: | 2012-07-27 | 最終更新日: | 2024-09-27 | 公開日: | 2012-08-24 | 識別子(ID): | N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)butanamide |
|
 | 0WO | 表記: | (2R,4S)-2-[(R)-carboxy{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}methyl]-5,5-dimethyl-1,3-thiazolidine-4-carbo
xylic acid | 組成式: | C19 H21 N3 O6 S | SMILES: | O=C(NC(C(=O)O)C1SC(C(N1)C(=O)O)(C)C)c3c(onc3c2ccccc2)C | InChi: | InChI=1S/C19H21N3O6S/c1-9-11(12(22-28-9)10-7-5-4-6-8-10)15(23)20-13(17(24)25)16-21-14(18(26)27)19(2,3)29-16/h4-8,13-14,16,21H,1-3H3,(H,20,23)(H,24,25)(H,26,27)/t13-,14-,16+/m0/s1 | 別名: | Oxacillin, hydroxylated form | 定義日: | 2012-07-27 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2R,4S)-2-[(R)-carboxy{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | MHS | 表記: | N1-METHYLATED HISTIDINE | 組成式: | C7 H11 N3 O2 | SMILES: | O=C(O)C(N)Cc1cncn1C | InChi: | InChI=1S/C7H11N3O2/c1-10-4-9-3-5(10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-methyl-L-histidine |
|
 | MHT | 表記: | (3S)-3-(methylsulfanyl)-1-azabicyclo[2.2.2]octane | 組成式: | C8 H15 N S | SMILES: | S(C2C1CCN(CC1)C2)C | InChi: | InChI=1S/C8H15NS/c1-10-8-6-9-4-2-7(8)3-5-9/h7-8H,2-6H2,1H3/t8-/m1/s1 | 定義日: | 2010-07-15 | 最終更新日: | 2024-09-27 | 識別子(ID): | (3S)-3-(methylsulfanyl)-1-azabicyclo[2.2.2]octane |
|
 | MHU | 表記: | 4-N,N-(DIMETHYLAMINO)-L-PHENYLALANINE | 組成式: | C12 H18 N2 O2 | SMILES: | O=C(O)C(NC)Cc1ccc(N(C)C)cc1 | InChi: | InChI=1S/C12H18N2O2/c1-13-11(12(15)16)8-9-4-6-10(7-5-9)14(2)3/h4-7,11,13H,8H2,1-3H3,(H,15,16)/t11-/m0/s1 | 定義日: | 2010-07-15 | 最終更新日: | 2024-09-27 | 識別子(ID): | 4-(dimethylamino)-N-methyl-L-phenylalanine |
|
 | MHV | 表記: | 4-OXO-L-PIPECOLIC ACID | 組成式: | C6 H9 N O3 | SMILES: | O=C(O)C1NCCC(=O)C1 | InChi: | InChI=1S/C6H9NO3/c8-4-1-2-7-5(3-4)6(9)10/h5,7H,1-3H2,(H,9,10)/t5-/m0/s1 | 定義日: | 2010-07-15 | 最終更新日: | 2024-09-27 | 識別子(ID): | (2S)-4-oxopiperidine-2-carboxylic acid |
|
 | MHW | 表記: | 3-HYDROXYPICOLINIC ACID | 組成式: | C6 H5 N O3 | SMILES: | O=C(O)c1ncccc1O | InChi: | InChI=1S/C6H5NO3/c8-4-2-1-3-7-5(4)6(9)10/h1-3,8H,(H,9,10) | 定義日: | 2010-07-15 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-hydroxypyridine-2-carboxylic acid |
|
 | MHY | 表記: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3,5-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 組成式: | C15 H15 F2 N3 O5 | SMILES: | NC(C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(F)c(c(c2)F)O)C(O)C | InChi: | InChI=1S/C15H15F2N3O5/c1-6(21)12(18)14-19-10(15(25)20(14)5-11(22)23)4-7-2-8(16)13(24)9(17)3-7/h2-4,6,12,21,24H,5,18H2,1H3,(H,22,23)/b10-4-/t6-,12+/m1/s1 | 定義日: | 2019-04-02 | 最終更新日: | 2024-09-27 | 公開日: | 2020-04-08 | 識別子(ID): | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3,5-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | MHZ | 表記: | 5'-DEOXY-5'-[(3-HYDRAZINOPROPYL)METHYLAMINO]ADENOSINE | 組成式: | C14 H24 N8 O3 | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)CN(CCCNN)C)N | InChi: | InChI=1S/C14H24N8O3/c1-21(4-2-3-20-16)5-8-10(23)11(24)14(25-8)22-7-19-9-12(15)17-6-18-13(9)22/h6-8,10-11,14,20,23-24H,2-5,16H2,1H3,(H2,15,17,18)/t8-,10-,11-,14-/m1/s1 | 定義日: | 2001-03-13 | 最終更新日: | 2024-09-27 | 識別子(ID): | 5'-deoxy-5'-[(3-hydrazinopropyl)(methyl)amino]adenosine |
|
 | 0WZ | 表記: | 3-(1H-pyrazol-1-yl)-L-tyrosine | 組成式: | C12 H13 N3 O3 | SMILES: | O=C(O)C(N)Cc1ccc(O)c(c1)n2nccc2 | InChi: | InChI=1S/C12H13N3O3/c13-9(12(17)18)6-8-2-3-11(16)10(7-8)15-5-1-4-14-15/h1-5,7,9,16H,6,13H2,(H,17,18)/t9-/m0/s1 | 定義日: | 2012-08-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-08-24 | 識別子(ID): | 3-(1H-pyrazol-1-yl)-L-tyrosine |
|
 | MIJ | 表記: | (2~{R},3~{S})-3-[[(2~{S})-3-cyclopropyl-2-[2-oxidanylidene-3-(2-phenylethanoylamino)pyridin-1-yl]propanoyl]amino]-~{N}-methyl-2-oxidanyl-4-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butanamide | 組成式: | C28 H35 N5 O6 | SMILES: | CNC(=O)[CH](O)[CH](C[CH]1CCNC1=O)NC(=O)[CH](CC2CC2)N3C=CC=C(NC(=O)Cc4ccccc4)C3=O | InChi: | InChI=1S/C28H35N5O6/c1-29-27(38)24(35)21(16-19-11-12-30-25(19)36)32-26(37)22(14-18-9-10-18)33-13-5-8-20(28(33)39)31-23(34)15-17-6-3-2-4-7-17/h2-8,13,18-19,21-22,24,35H,9-12,14-16H2,1H3,(H,29,38)(H,30,36)(H,31,34)(H,32,37)/t19-,21-,22-,24+/m0/s1 | 定義日: | 2022-07-27 | 最終更新日: | 2024-09-27 | 公開日: | 2023-08-16 | 識別子(ID): | (2~{R},3~{S})-3-[[(2~{S})-3-cyclopropyl-2-[2-oxidanylidene-3-(2-phenylethanoylamino)pyridin-1-yl]propanoyl]amino]-~{N}-methyl-2-oxidanyl-4-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butanamide |
|